To further validate the function of IGF2BP2 in promoting oncogenesis of HNSCC, a xenograft model was generated by subcutaneous injection of IGF2BP2-silenced FaDu cells into mice. This evidence concerns the gene IGF2BP2 and head and neck squamous cell carcinoma.